SME Times is powered by   
Search News
Just in:   • Adani Group to invest Rs 57,575 crore in Odisha  • 'Dollar Distancing' finally happening? Time for India to pitch Rupee as credible alternative: SBI Ecowrap  • 49% Indian startups now from tier 2, 3 cities: Jitendra Singh  • 'India ranks 3rd in global startup ecosystem & number of unicorns'  • LinkedIn lays off entire global events marketing team: Report 
Last updated: 08 May, 2015  

Pharma Project Mgmt Conference to be Held on June 29-30

PR Newswire | 07 May, 2015
India's Best Pharma Project Management Conference to be Held on 29th-30th June 2015

MUMBAI: CPhI, which hosts a number of successful and well-respected pharmaceutical conferences, are conducting their 3rd Annual Pharma Project Management Conference, 29th - 30th June 2015 at The Westin in Mumbai. The conference is focused on addressing challenges faced by project managers while handling projects in complex environment and gaining practical insights on quality and timely delivery of projects.

Some of the important topics being discussed at the conference include: 

  • Discovering various practical tools to manage the portfolio by efficient project prioritisation to explore the significance of portfolio management
  • Determining risk management practices and focusing on systematic approach in handling risks to avoid future contingencies
  • Bridging cultural gaps in projects and showcasing issues that can be caused by misunderstandings of cultural differences
  • Setting up of PMO as a means of providing strategic and tactical leadership for improving consistency, transparency and effectiveness of project management process

This conference has had more than 150+ delegates from companies like Agila, Alkem Laboratories, Astra Zeneca, Aurobindo, Biocon, Biological E, Cipla, Dishman Pharmaceuticals, Dr.Reddys Labs, Emcure, Famy Care, Fresenius Kabi Oncology, Glatt, Glenmark, IPCA Laboratories, Jubilant Life Sciences, Kinapse, KPMG, Laila Nutraceuticals, MacChem Products, Merck, Mylan, Piramal Health Care, RPG Life Sciences, Sanofi, Shasun Pharmaceuticals, Sun Pharma, Teva, The Himalaya Drug Company, Torrent Pharma and many more.

Post Show Report:  | Complete Agenda:  | LinkedIn Group:

Pharma Experts: 

  • Mr. Dogan Fidan, VP Early Stage Products, Sanofi, Paris
  • Monica Semeniuk, Sessional Lecturer and Research Assistant, Simon Fraser University, Canada
  • Ramesh Swaminathan, CFO & President, Lupin
  • Subbu Parameswaran, PMP, Partner & Chief Leadership Architect, The Strategist
  • Srivatsan Krishnan, Head - R&D Operations and IT, Bristol-Myers Squibb, Biocon
  • Kashyap Avashia, Head PMO, Dr.Reddy's
  • Ravindra Gajendragadkar, Director, PMDISHA
  • Mr. Varadarajan, Director & Head of Commercial Operations Lab Asia, Merck Millipore
  • Megha Thakkar, Project Manager- NDDS, Cipla
  • Mr. John Robert, GM, Sun Pharma

For further information about the summit visit

About UBM India 

UBM India is India's leading live media and events company that engages people and enriches businesses. We at UBM India provide the industry with platforms that bring together buyers and sellers from around the world, through a portfolio of exhibitions, content led conferences & seminars, tech media, live events, data services and powerful media brands. UBM India hosts over 20 large scale exhibitions and 40 conferences across the country every year; thereby enabling trade across multiple industry verticals. A UBM Asia Company, UBM India has offices across Mumbai, New Delhi, Bangalore and Chennai. UBM Asia is owned by UBM plc which is listed on the London Stock Exchange. UBM Asia is the leading exhibition organiser in Asia and the biggest commercial organiser in mainland China, India and Malaysia. For further details, please visit

Media Contact:
Mustafa Nalwalla
Marketing Manager, UBM India

Print the Page Add to Favorite
Share this on :

Please comment on this story:
Subject :
(Maximum 1500 characters)  Characters left 1500
Your name:

  Customs Exchange Rates
Currency Import Export
US Dollar
UK Pound
Japanese Yen 58.85 56.85
As on 13 Aug, 2022
  Daily Poll
COVID-19 has directly affected your business
 Can't say
  Commented Stories
» GIC Re's revenue from obligatory cession threatened(1)
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter